trending Market Intelligence /marketintelligence/en/news-insights/trending/LeI4GjWza32zgHeNXnQtTQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Editas Medicine appoints CEO

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Editas Medicine appoints CEO

Editas Medicine Inc.'s board appointed Cynthia Collins as the company's president and CEO.

Collins was serving as the genome-editing company's interim CEO since March 1.

Prior to joining Massachusets-based Editas Medicine, Collins was the CEO of Human Longevity Inc., which is building a database on human genotypes and phenotypes and using machine learning to help develop new medicines.

Collins is also a member of the board for the ARM Foundation for Cell and Gene Medicine, Triumvira Immunologics Inc., DermTech Inc. and Biocare Medical LLC.